CClinicalTrials.gg
CompletedNCT07219329Updated Aug 28, 2026

The Feasibility of a Nurse-Initiated Weighted Blanket in Orthopedic Surgical Patients Undergoing Total Knee Arthroplasty

An interventional study of Weighted Blanket in Total Knee Replacement, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to explore the acceptability and feasibility of weighted blankets in total knee replacement (TKR) patients. The study also aims to measure the difference in anxiety of adult orthopedic patients in need of total knee arthroplasty surgery who receive weighted blanket before and after surgery compared to those who receive a non-weighted blanket.

02

Conditions studied

  • Total Knee Replacement

Browse trials for

Keywords

  • anxiety
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 30 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.

Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Adults aged 18 years and older
  2. Adults undergoing elective total knee arthroplasty at NYU Langone Orthopedic Hospital.
  3. Adults who are scheduled to receive spinal anesthesia.
  4. Subjects with a planned same day discharge to home from the PACU

Exclusion criteria

Exclusion Criteria:

  1. cognitive disability that would interfere with their ability to complete the study's pre and post assessments (e.g. dementia, non-verbal)
  2. subject disclosed history of pre-existing anxiety disorder, claustrophobia, epilepsy, respiratory conditions (e.g. obstructive sleep apnea (OSA), asthma), skin conditions (e.g. pressure injury), which are contradictions for weighted blanket.
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Weighted blanket

    Participants will receive a weighted blanket in the preoperative holding room and in the Post-Anesthesia Care Unit (PACU) after surgery.

    Device: Weighted Blanket

  • No intervention
    Standard of care

    Participants will receive a non-weighted blanket in the preoperative holding room prior to and in the PACU after surgery per standard of care.

Interventions

  • DeviceWeighted Blanket

    5lb weighted blanket

06

What researchers measure

Primary outcomes

  1. Time participants used weighted blanket

    Outcome measure assessed via investigator-created Weighted Blanket Feasibility Question in Post-Anesthesia Care Unit (PACU). Question asks "How long would you estimate that you used the weighted blanket?" Patient-reported estimate in minutes.

    Time frame: PACU discharge (~1-3 hours post-surgery)

  2. Number of participants who would use a weighted blanket in the future

    Outcome measure via investigator-created Weighted Blanket Acceptability Question in PACU. The question asks the participant "If you were offered a weighted blanket in the future, would you choose to use it?" with choices of "yes", "no", and "unsure" and then asked to explain their choice.

    Time frame: PACU discharge (~1-3 hours post-surgery)

Secondary outcomes

  1. Change in short Spielberger State-Trait Anxiety Inventory (SSTAI) score

    The STAI-5 consists of 5 items relating to anxiety, each item is scored on a 4-point scale. Scores range from 5 to 20, with higher scores indicating more anxiety.

    Time frame: Baseline (before blanket application), PACU discharge (~1-3 hours post-surgery)

  2. Change in Numeric Pain Rating Scale (NPRS) score

    Pain is assessed on the NPRS from 0 (No pain) to 10 (Severe pain).

    Time frame: Baseline (before blanket application), PACU discharge (~1-3 hours post-surgery)

  3. Richmond Agitation-Sedation Scale (RASS) score

    The RASS consists of a 10-point scale.. Positive scores indicate agitation, with +4 being the most severe (combative), and negative scores indicate sedation, with -5 being the deepest level of sedation (unarousable). A score of 0 indicates the patient is alert and calm.

    Time frame: PACU discharge (~1-3 hours post-surgery)

  4. Change in heart rate

    Time frame: Baseline (before blanket application), PACU discharge (~1-3 hours post-surgery)

  5. Change in blood pressure

    Time frame: Baseline (before blanket application), PACU discharge (~1-3 hours post-surgery)

07

Study locations

1 site
  • NYU Langone Health
    New York, New York 10016, United States
08

References and documents

Individual participant data

Plan to share: No — Study participants did not provide consent for data sharing beyond the study team and institutional oversight. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07219329
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Oct 21, 2025
Start date
Feb 4, 2026
Primary completion
Aug 6, 2026
Completion
Aug 6, 2026
Last update
Aug 28, 2026

Study contacts

Diana Wong, MS, RN, CPAN, ONC
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion